Schonfeld Strategic Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Buy |
|
|||||
|
2025
Q1 | $4.59M | Buy |
|
|||||
|
2024
Q4 | $1.64M | Buy |
|
|||||
|
2024
Q3 | $1.3M | Sell |
|
|||||
|
2024
Q2 | $2.8M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $853K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $242K | Sell |
|
|||||
|
2022
Q3 | $2.62M | Buy |
|
|||||
|
2022
Q2 | $1.81M | Sell |
|
|||||
|
2022
Q1 | $4.68M | Buy |
|
|||||
|
2021
Q4 | $737K | Buy |
|
|||||
|
2021
Q3 | $423K | Sell |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2021
Q1 | $201K | Sell |
|
|||||
|
2020
Q4 | $650K | Sell |
|
|||||
|
2020
Q3 | $830K | Buy |
|
|||||
|
2020
Q2 | $797K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.37M | Sell |
|
|||||
|
2019
Q3 | $2.61M | Sell |
|
|||||
|
2019
Q2 | $8.47M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $89K | Sell |
|
|||||
|
2018
Q3 | $418K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $76K | Sell |
|
|||||
|
2017
Q1 | $643K | Buy |
|